SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.
Saved in:
| Title: | SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer. |
|---|---|
| Authors: | Mayer, E. L.1, Dhakil, S.2, Patel, T.3, Sundaram, S.4, Fabian, C.5, Kozloff, M.6, Qamar, R.7, Volterra, F.8, Parmar, H.9, Samant, M.10, Burstein, H. J.1 |
| Source: | Annals of Oncology. Dec2010, Vol. 21 Issue 12, p2370-2376. 7p. 1 Diagram, 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1093/annonc/mdq260 |
